The advisory panel will be held June 27 through June 28 and include scientists, researchers, patients and medical professionals. These experts will help regulators decide whether new testing and review requirements will be implemented before new metal-on-metal hip implants can be sold in the United States.
More Articles on Orthopedic Devices:
FDA Sends Warning Letters to California Orthopedic & Spine Device Companies
FDA Publishes Guidance for Pre-market Approvals
Wright Medical Group Names James Lightman Senior Vice President
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.